Literature DB >> 17154419

The role of phosphorylation on the structure and dynamics of phospholamban: a model from molecular simulations.

Sergio Pantano1, Ernesto Carafoli.   

Abstract

Phospholamban (PLB) is a small membrane protein that regulates the activity of the calcium ATP-ase in the cardiac, slow-twitch, and smooth muscle sarcoplasmic reticulum through the reversible phosphorylation of Ser16. We present here a comparative molecular dynamics study of unmodified and phosphorylated PLB immersed in a phospholipid membrane. The study has been performed under different ionic strength conditions, using the NMR structures of two PLB variants determined in mixed organic solvent and dodecylphosphocholine micelles. The simulations indicate that all PLB forms studied display a highly dynamic behavior of the N-terminal cytoplasmic moiety, with a decrease of its helical content in the phosphorylated forms. The cytoplasmic domain undergoes large collective motions sampling conformations parallel as well as perpendicular to the membrane surface in all the simulations. The transmembrane domain retains a tightly folded helical conformation with a small tilt with respect to the membrane plane probably induced by the presence of Asn30 and Asn34 within the hydrophobic environment. Furthermore, the phosphoric group on Ser16 establishes transient electrostatic interactions with the phospholipid heads. We propose a model in which phosphorylation diminishes the probability of interactions of PLB with residues near Lys400 in the SERCA pump, thus relieving its inhibition. (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17154419     DOI: 10.1002/prot.21239

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  12 in total

1.  Structure, dynamics, and ion conductance of the phospholamban pentamer.

Authors:  Christopher Maffeo; Aleksei Aksimentiev
Journal:  Biophys J       Date:  2009-06-17       Impact factor: 4.033

2.  Effect of membrane thickness on conformational sampling of phospholamban from computer simulations.

Authors:  Maryam Sayadi; Seiichiro Tanizaki; Michael Feig
Journal:  Biophys J       Date:  2010-03-03       Impact factor: 4.033

3.  Self-guided Langevin dynamics study of regulatory interactions in NtrC.

Authors:  Ana Damjanović; Bertrand García-Moreno E; Bernard R Brooks
Journal:  Proteins       Date:  2009-09

Review 4.  Perturbations of Native Membrane Protein Structure in Alkyl Phosphocholine Detergents: A Critical Assessment of NMR and Biophysical Studies.

Authors:  Christophe Chipot; François Dehez; Jason R Schnell; Nicole Zitzmann; Eva Pebay-Peyroula; Laurent J Catoire; Bruno Miroux; Edmund R S Kunji; Gianluigi Veglia; Timothy A Cross; Paul Schanda
Journal:  Chem Rev       Date:  2018-02-28       Impact factor: 60.622

5.  Revised AMBER parameters for bioorganic phosphates.

Authors:  T Steinbrecher; J Latzer; D A Case
Journal:  J Chem Theory Comput       Date:  2012-09-12       Impact factor: 6.006

6.  Phospholamban modulates the functional coupling between nucleotide domains in Ca-ATPase oligomeric complexes in cardiac sarcoplasmic reticulum.

Authors:  Linda T L Chen; Qing Yao; Thereza A Soares; Thomas C Squier; Diana J Bigelow
Journal:  Biochemistry       Date:  2009-03-24       Impact factor: 3.162

7.  An allosteric mechanism inferred from molecular dynamics simulations on phospholamban pentamer in lipid membranes.

Authors:  Peng Lian; Dong-Qing Wei; Jing-Fang Wang; Kuo-Chen Chou
Journal:  PLoS One       Date:  2011-04-15       Impact factor: 3.240

8.  A fully atomistic model of the Cx32 connexon.

Authors:  Sergio Pantano; Francesco Zonta; Fabio Mammano
Journal:  PLoS One       Date:  2008-07-02       Impact factor: 3.240

9.  Molecular Dynamics Simulations of the Human Glucose Transporter GLUT1.

Authors:  Min-Sun Park
Journal:  PLoS One       Date:  2015-04-28       Impact factor: 3.240

10.  Molecular dynamics simulations highlight structural and functional alterations in deafness-related M34T mutation of connexin 26.

Authors:  Francesco Zonta; Damiano Buratto; Chiara Cassini; Mario Bortolozzi; Fabio Mammano
Journal:  Front Physiol       Date:  2014-03-04       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.